Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein

L E Hughes1, P A Smith, S Bonell

  • 1Division of Infection, Immunity and Inflammatory Diseases, King's College London, Waterloo Campus, London, SE1 9NN, UK.

Insights

This study found elevated antibodies to bacterial peptides in multiple sclerosis (MS) patients, suggesting molecular mimicry may contribute to MS pathogenesis. Bacterial infections could play a role in this neurological disease.

Area of Science:

  • Neuroimmunology
  • Microbiology
  • Pathogenesis of Multiple Sclerosis

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
  • The role of infectious agents, particularly bacteria, in MS pathogenesis is an area of ongoing research.
  • Molecular mimicry, where microbial antigens resemble host antigens, is a proposed mechanism for autoimmune diseases like MS.

Purpose of the Study:

  • To investigate the potential role of molecular mimicry between bacterial components and myelin antigens in the pathogenesis of multiple sclerosis.
  • To examine antibody responses to specific bacterial peptide sequences and their cross-reactivity with myelin components in MS patients.

Main Methods:

  • Antibody levels against mimicry peptide sequences from Acinetobacter and Pseudomonas aeruginosa, as well as myelin basic protein (MBP) and myelin oligodendrocyte glycoprotein (MOG), were measured in MS patients and controls.
  • Cross-reactivity assays were performed using antisera against MBP and MOG with bacterial peptides.

Main Results:

  • Antibodies to mimicry peptides from Acinetobacter, P. aeruginosa, MBP, and MOG were significantly elevated in MS patients compared to controls (p<0.001 for all).
  • Antisera against MBP (residues 110-124) showed reactivity with Acinetobacter and Pseudomonas peptides.
  • MOG (residues 43-57) antisera reacted with an Acinetobacter peptide.

Conclusions:

  • The findings demonstrate elevated antibody responses to bacterial mimicry peptides in MS patients, suggesting a potential role for bacterial infections in MS pathogenesis.
  • Molecular mimicry is not limited to viral antigens, and bacterial components may trigger autoimmune responses in MS.
  • Further research is warranted to elucidate the precise contribution of these cross-reactive antibodies to the neuropathology of MS.